Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

DenmarkBack to Denmark

Clinical trials in Silkeborg – page 17

687 clinical trials in Silkeborg, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Silkeborg at a glance
687
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

687 trials in Silkeborg

Open in trial search

Ependymoma

Recruiting

Study on Ependymoma Treatment in Children, Adolescents, and Young Adults Using Cisplatin, Cyclophosphamide, Etoposide, and a Drug Combination

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years
  • Substances:Cisplatin
  • Sponsor:Centre Leon Berard

Rhabdomyosarcoma

Recruiting

Study of drug combinations including irinotecan, ifosfamide, vincristine, dactinomycin, regorafenib and other agents for children and adults with rhabdomyosarcoma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:The University Of Birmingham

Neuroblastoma

Recruiting

Study on High-Risk Neuroblastoma Treatment with Busulfan, Melphalan, and Drug Combination for Patients with Insufficient Metastatic Response

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years
  • Substances:Busulfan
  • Sponsor:Institut Gustave Roussy

Fungal infection

Recruiting

Study on Fluconazole and Sodium Chloride to Prevent Fungal Infections in Patients Undergoing Cystectomy

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Fluconazole
  • Sponsor:Region Hovedstaden

Glioblastoma

Recruiting

Study on Lomustine with or without Additional Brain Radiation for Patients with Recurrent Glioblastoma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Lomustine
  • Sponsor:European Organisation For Research And Treatment Of Cancer

Systemic scleroderma+1

Recruiting

Study on the Effects of Belimumab in Adults with Systemic Sclerosis-Associated Interstitial Lung Disease

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Belimumab
  • Sponsor:Glaxosmithkline Research & Development Limited

Cervix carcinoma

Recruiting

Study on the Effectiveness of Volrustomig in Women with High-Risk Locally Advanced Cervical Cancer After Chemoradiation Therapy

Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Infliximab
  • Sponsor:AstraZeneca AB

Interstitial lung disease

Recruiting

Study on the Effects of Morphine Sulfate for Relieving Breathlessness and Cough in Patients with Fibrotic Interstitial Lung Disease

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Morphine Sulfate
  • Sponsor:Region Midtjylland

Non-small cell lung cancer metastatic

Recruiting

Study Comparing MK-2870 and Pembrolizumab Combination to Pembrolizumab Alone for Patients with Metastatic Non-Small Cell Lung Cancer with High PD-L1 Levels

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Merck Sharp & Dohme LLC

Myelodysplastic syndrome

Recruiting

Study on Azacitidine for Patients with Myelodysplastic Syndrome After Stem Cell Transplantation

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Karolinska University Hospital

Medical device site joint infection

Recruiting

Study on Reducing Prosthetic Joint Infection in Hip Replacement Patients Using Vancomycin, Tobramycin, and Saline-Infused Bone Graft

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Saline
  • Sponsor:Region Oestergoetland

Diabetes mellitus+1

Recruiting

Study of Denosumab Effects on Muscle Strength and Insulin Sensitivity in Patients with Postmenopausal Osteoporosis and Diabetes Mellitus

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Denosumab
  • Sponsor:Region Midtjylland

Other cities in Denmark

The busiest research cities in the country

All 45 cities in Denmark

Clinical research in Silkeborg

What the registry says about research in the country

01 Pain Management & Anesthesia

Innovative research focusing on post-surgical pain management and anesthetic techniques, particularly studying the effectiveness of Popliteal Plexus Block in knee surgeries.

  • Post-surgical pain control
  • Local anesthetic optimization
  • Multimodal pain management

Studies evaluating different volumes of anesthetic agents to improve patient outcomes after orthopedic procedures.

02 Musculoskeletal Disorders

Comprehensive trials investigating treatments for various joint and muscle conditions, including hand osteoarthritis and Dupuytren Contracture.

  • Arthritis management
  • Joint mobility improvement
  • Novel therapeutic approaches

Research exploring both medication-based and surgical interventions for musculoskeletal conditions.

03 Chronic Disease Management

Advanced research into chronic conditions including COPD and Type 2 diabetes, with focus on screening and treatment optimization.

  • Respiratory health
  • Cardiovascular screening
  • Disease prevention strategies

Innovative approaches to managing long-term conditions through personalized treatment strategies.

Back to DenmarkAll countries
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.